A major challenge for cancer-specific therapeutics resides around specificity and recurrence of cancer targets. At the 6th Course on Immunity and Cancer Immunotherapy June 20-23, sponsored by Mnemo and organized by Institut Curie and CIML Biology, Mnemo scientists presented three posters. View the posters below to learn more about how Mnemo is tackling problems around specificity and recurrence of cancer targets by discovering novel cancer targets while boosting immune activity to treat solid tumors.
Preclinical development of MSLN-targeting CAR T cells for enhanced long-term in vivo efficacy